HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ivan Bièche Selected Research

indimitecan

1/2020BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ivan Bièche Research Topics

Disease

79Neoplasms (Cancer)
10/2022 - 03/2002
62Breast Neoplasms (Breast Cancer)
03/2022 - 03/2002
21Neoplasm Metastasis (Metastasis)
10/2021 - 04/2006
19Carcinogenesis
10/2022 - 03/2002
10Plexiform Neurofibroma
10/2022 - 06/2004
9Triple Negative Breast Neoplasms
01/2021 - 01/2012
8Carcinoma (Carcinomatosis)
11/2019 - 09/2007
7Fibrosis (Cirrhosis)
01/2020 - 02/2005
6Neurofibrosarcoma (MPNST)
10/2022 - 06/2004
4Neurofibroma
10/2022 - 06/2004
3Squamous Cell Carcinoma of Head and Neck
12/2021 - 12/2019
3Residual Neoplasm
11/2021 - 01/2016
3Sarcoma (Soft Tissue Sarcoma)
11/2019 - 03/2011
3Alzheimer Disease (Alzheimer's Disease)
01/2017 - 08/2015
3Necrosis
05/2016 - 02/2009
3Chronic Hepatitis C
01/2015 - 09/2008
3Ischemia
07/2014 - 12/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014 - 09/2003
3Infections
03/2012 - 02/2005
3Neurofibromatosis 1 (Neurofibromatosis Type I)
11/2011 - 01/2007
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 10/2008
2Melanoma (Melanoma, Malignant)
07/2021 - 04/2007
2Thrombosis (Thrombus)
01/2020 - 06/2008
2Tetraploidy
01/2018 - 02/2011
2Glioblastoma (Glioblastoma Multiforme)
01/2018 - 06/2010
2Colorectal Neoplasms (Colorectal Cancer)
10/2017 - 12/2016
2Inborn Genetic Diseases (Disease, Hereditary)
01/2017 - 09/2011
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 08/2015
2Atrophy
08/2015 - 09/2011
2Neuroblastoma
01/2015 - 09/2003
2Glioma (Gliomas)
05/2008 - 01/2007
2Liver Cirrhosis (Hepatic Cirrhosis)
02/2007 - 02/2005
2Transitional Cell Carcinoma
06/2006 - 03/2006
2Hepatocellular Carcinoma (Hepatoma)
04/2006 - 10/2003

Drug/Important Bio-Agent (IBA)

32Messenger RNA (mRNA)IBA
11/2018 - 03/2002
27Proteins (Proteins, Gene)FDA Link
10/2022 - 09/2003
11Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2003
11Estrogen ReceptorsIBA
01/2021 - 03/2002
8Estrogens (Estrogen)FDA Link
01/2021 - 03/2002
8Estrogen Receptor alphaIBA
12/2014 - 04/2003
7Phenobarbital (Luminal)FDA Link
01/2021 - 08/2014
7TamoxifenFDA LinkGeneric
05/2018 - 04/2003
7RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2008 - 03/2002
6Biological ProductsIBA
03/2022 - 10/2002
6Phosphotransferases (Kinase)IBA
01/2022 - 05/2003
6Hormones (Hormone)IBA
11/2019 - 03/2002
6Transcription Factors (Transcription Factor)IBA
11/2018 - 03/2004
4CytokinesIBA
01/2022 - 06/2004
4DNA (Deoxyribonucleic Acid)IBA
11/2021 - 10/2003
4Matrix Metalloproteinase 14 (MT1-MMP)IBA
01/2021 - 05/2014
4Metalloproteases (Metalloproteinases)IBA
01/2021 - 05/2014
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 12/2012
4EverolimusFDA Link
07/2018 - 08/2014
4MicroRNAs (MicroRNA)IBA
10/2016 - 01/2011
4matrigelIBA
07/2015 - 12/2010
4InterferonsIBA
01/2015 - 02/2005
4ErbB Receptors (EGF Receptor)IBA
01/2014 - 03/2006
4LigandsIBA
06/2010 - 09/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2022 - 07/2014
3palbociclibIBA
03/2022 - 01/2020
3Circulating Tumor DNAIBA
01/2022 - 04/2019
3OligonucleotidesIBA
01/2022 - 12/2010
3Tyrosine Kinase InhibitorsIBA
11/2021 - 06/2011
3Fulvestrant (Faslodex)FDA Link
01/2021 - 08/2014
3Interleukin-8 (Interleukin 8)IBA
01/2019 - 12/2007
3RNA (Ribonucleic Acid)IBA
11/2018 - 09/2003
3Protein Isoforms (Isoforms)IBA
11/2018 - 11/2004
3Small Interfering RNA (siRNA)IBA
01/2018 - 01/2015
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018 - 12/2012
3Progesterone Receptors (Progesterone Receptor)IBA
01/2018 - 01/2012
3CholesterolIBA
01/2017 - 07/2009
3Ribavirin (Virazole)FDA LinkGeneric
01/2015 - 03/2012
3Estrogen Receptor Modulators (Antiestrogen)IBA
12/2014 - 03/2002
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2014 - 06/2004
3EnzymesIBA
07/2009 - 09/2003
2Aromatase InhibitorsIBA
03/2022 - 01/2019
2LipidsIBA
01/2022 - 01/2017
2Oncogene Proteins (Oncogene Protein)IBA
01/2022 - 11/2019
2flotillinsIBA
01/2022 - 01/2018
2Viral DNAIBA
01/2022 - 11/2019
2Cetuximab (Erbitux)FDA Link
12/2021 - 04/2015
2Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 01/2020
2Co-Repressor ProteinsIBA
01/2020 - 04/2003
2Pharmaceutical PreparationsIBA
12/2019 - 01/2017
2CortactinIBA
12/2018 - 05/2014
2Apoptosis Regulatory ProteinsIBA
10/2018 - 01/2006
2WW Domain-Containing OxidoreductaseIBA
10/2018 - 05/2015
2Celecoxib (Celebrex)FDA Link
01/2018 - 12/2016
2Cholesterol 24-Hydroxylase (CYP46A1)IBA
11/2015 - 08/2015
2Amyloid (Amyloid Fibrils)IBA
11/2015 - 08/2015
2ChemokinesIBA
10/2015 - 12/2007
2InterleukinsIBA
03/2012 - 02/2009
2Untranslated RNA (Noncoding RNA)IBA
11/2011 - 04/2007
2Uroplakin IIIBA
10/2008 - 09/2007
2tributyl phosphate (TBP)IBA
10/2008 - 09/2007
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
05/2008 - 07/2004

Therapy/Procedure

32Therapeutics
03/2022 - 04/2003
11Drug Therapy (Chemotherapy)
03/2021 - 12/2012
3Injections
12/2021 - 03/2011
2Precision Medicine
07/2021 - 04/2016